IL239309A0 - Methods for the treatment and prevention of respiratory conditions - Google Patents

Methods for the treatment and prevention of respiratory conditions

Info

Publication number
IL239309A0
IL239309A0 IL239309A IL23930915A IL239309A0 IL 239309 A0 IL239309 A0 IL 239309A0 IL 239309 A IL239309 A IL 239309A IL 23930915 A IL23930915 A IL 23930915A IL 239309 A0 IL239309 A0 IL 239309A0
Authority
IL
Israel
Prior art keywords
treating
methods
respiratory conditions
preventing respiratory
preventing
Prior art date
Application number
IL239309A
Other languages
English (en)
Hebrew (he)
Original Assignee
Mesoblast Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mesoblast Inc filed Critical Mesoblast Inc
Publication of IL239309A0 publication Critical patent/IL239309A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
IL239309A 2012-12-12 2015-06-09 Methods for the treatment and prevention of respiratory conditions IL239309A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261736352P 2012-12-12 2012-12-12
PCT/AU2013/001454 WO2014089625A1 (en) 2012-12-12 2013-12-12 Methods of treating or preventing respiratory conditions

Publications (1)

Publication Number Publication Date
IL239309A0 true IL239309A0 (en) 2015-07-30

Family

ID=50933587

Family Applications (1)

Application Number Title Priority Date Filing Date
IL239309A IL239309A0 (en) 2012-12-12 2015-06-09 Methods for the treatment and prevention of respiratory conditions

Country Status (11)

Country Link
US (3) US10028979B2 (https=)
EP (1) EP2931373B1 (https=)
JP (5) JP6313327B2 (https=)
KR (1) KR101748712B1 (https=)
CN (2) CN115919901A (https=)
AU (4) AU2013360026B2 (https=)
CA (1) CA2893951C (https=)
ES (1) ES2759281T3 (https=)
IL (1) IL239309A0 (https=)
SG (2) SG10201807682PA (https=)
WO (1) WO2014089625A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115919901A (zh) 2012-12-12 2023-04-07 麦瑟布莱斯特公司 治疗或预防呼吸病症的方法
US20170296589A1 (en) * 2014-09-23 2017-10-19 Case Western Reserve University Compositions and methods for treating lung remodeling diseases
CA3074470C (en) * 2017-09-15 2024-01-16 Cynata Therapeutics Limited Method for treating allergic airways disease (aad)/ asthma
EP4098267A4 (en) * 2020-01-30 2024-03-06 JCR Pharmaceuticals Co., Ltd. MEDICINAL COMPOSITION COMPRISING CELLS DERIVED FROM DENTAL PULP
JP7551340B2 (ja) * 2020-06-04 2024-09-17 株式会社三共 遊技機
JP7551341B2 (ja) * 2020-06-04 2024-09-17 株式会社三共 遊技機
CN118800458B (zh) * 2024-09-14 2024-11-15 吉林大学 一种心胸外科术后并发症预测方法及系统

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003901668A0 (en) 2003-03-28 2003-05-01 Medvet Science Pty. Ltd. Non-haemopoietic precursor cells
EP1483371B1 (en) * 2002-02-19 2007-06-27 Medipost, Co., Ltd. Isolation and culture-expansion methods of mesenchymal stem/progenitor cells from umbilical cord blood, and differentiation method of umbilical cord blood-derived mesenchymal stem/progenitor cells into various mesenchymal tissues
US20080095749A1 (en) * 2004-03-22 2008-04-24 Sudeepta Aggarwal Mesenchymal stem cells and uses therefor
CA2866468C (en) * 2004-09-24 2019-09-03 Mesoblast, Inc. Generating multipotential expanded mesenchymal precursor cell progeny (memp) from mesenchymal progenitor cells (mpc) and stimulation factor
WO2006108229A1 (en) * 2005-04-12 2006-10-19 Angioblast Systems, Inc. Isolation of adult multipotential cells by tissue non-specific alkaline phosphatase
WO2008036374A2 (en) 2006-09-21 2008-03-27 Medistem Laboratories, Inc. Allogeneic stem cell transplants in non-conditioned recipients
US20090053182A1 (en) 2007-05-25 2009-02-26 Medistem Laboratories, Inc. Endometrial stem cells and methods of making and using same
EP3424514B1 (en) * 2007-08-06 2022-05-11 Mesoblast, Inc. Tnap+ mesenchymal precursor cells for use in treating connective tissue diseases
US20100247577A1 (en) * 2007-10-17 2010-09-30 Txcell Tr1 cells, mesenchymal stem cells and uses thereof
CA2735800C (en) * 2008-09-03 2018-05-01 Angioblast Systems, Inc. Expansion of haemopoietic precursors
CA2803641A1 (en) * 2010-07-02 2012-01-05 Mesoblast, Inc. Treatment of t-cell mediated immune disorders
CA2829586C (en) * 2011-03-11 2021-03-02 Children's Medical Center Corporation Methods and compositions relating to mesenchymal stem cell exosomes
WO2012162754A1 (en) * 2011-06-03 2012-12-06 Mesoblast, Inc Methods of treating or preventing neurological diseases
CN115919901A (zh) 2012-12-12 2023-04-07 麦瑟布莱斯特公司 治疗或预防呼吸病症的方法

Also Published As

Publication number Publication date
US20190046575A1 (en) 2019-02-14
JP6665218B2 (ja) 2020-03-13
AU2013360026A1 (en) 2015-07-02
KR20150090237A (ko) 2015-08-05
WO2014089625A1 (en) 2014-06-19
CN115919901A (zh) 2023-04-07
HK1210077A1 (en) 2016-04-15
US10028979B2 (en) 2018-07-24
SG10201807682PA (en) 2018-10-30
US20150306146A1 (en) 2015-10-29
CA2893951C (en) 2022-05-03
JP2018118987A (ja) 2018-08-02
AU2020202022A1 (en) 2020-04-09
SG11201504352TA (en) 2015-07-30
AU2022209219B2 (en) 2025-08-14
AU2018226514A1 (en) 2018-09-27
AU2018226514B2 (en) 2020-01-02
EP2931373B1 (en) 2019-08-21
US20200289578A1 (en) 2020-09-17
CA2893951A1 (en) 2014-06-19
JP2016502980A (ja) 2016-02-01
CN105377274A (zh) 2016-03-02
EP2931373A1 (en) 2015-10-21
US10688134B2 (en) 2020-06-23
JP2022065132A (ja) 2022-04-26
AU2013360026B2 (en) 2018-06-21
JP2020097618A (ja) 2020-06-25
JP6313327B2 (ja) 2018-04-18
JP2024041904A (ja) 2024-03-27
EP2931373A4 (en) 2016-05-04
KR101748712B1 (ko) 2017-06-19
ES2759281T3 (es) 2020-05-08
AU2022209219A1 (en) 2022-08-18
JP7420844B2 (ja) 2024-01-23

Similar Documents

Publication Publication Date Title
IL238254A0 (en) Cancer treatment methods
IL237528A0 (en) Methods for preventing and treating preeclampsia
PL2892525T3 (pl) Sposoby leczenia dystrofii mięśniowej
ZA201500152B (en) Methods of treating arthritis
GB201217296D0 (en) Method of treatment and/or prevention
EP2879689A4 (en) METHOD FOR THE TREATMENT OF ATHEROSCLEROSIS
IL260115A (en) Methods for treating fibrosis (Leifat)
GB201506561D0 (en) Treatment of amblyopia
IL239309A0 (en) Methods for the treatment and prevention of respiratory conditions
ZA201406567B (en) Method for treatment of labor arrest
IL245538A0 (en) Treatment methods for abnormal muscle activity
IL237449A0 (en) Methods for treating health conditions related to hair
ZA201408058B (en) Compositions and methods for the treatment of epilepsy
HUE036419T2 (hu) Légzõszervi depresszió kezelése
GB201221118D0 (en) Methods of treatment
GB201216748D0 (en) Methods of treatment
GB201216740D0 (en) Methods of treatment
GB201206324D0 (en) Methods of treatment
GB201206330D0 (en) Methods of treatment
GB201206326D0 (en) Methods of treatment
GB201206325D0 (en) Methods of treatment
GB201221032D0 (en) Method of treatment
GB201207894D0 (en) Method of treatment
ZA201501068B (en) Methods for prevention and treatment of preeclampsia
IL233740A0 (en) Treatment of liver diseases